Skip to main navigation
X
Announcing our new website:
KindredBio Equine
  • Sign In
KindredBio
  • About
    • Background
    • KindredBio Leadership
    • Board Of Directors
  • Technology
    • Veterinary Recombinant Biologics
    • Manufacturing Process
  • Products
    • Mirataz™ (mirtazapine transdermal ointment)
  • Pipeline
    • Pipeline
    • Zimeta™ (dipyrone)
    • epoCat™ (feline recombinant erythropoietin)
  • Investors

    Investor Relations

    • Investor Overview
    • Press Releases
    • Events and Presentations
    • Corporate Governance
      • Governance Documents
      • Committee Composition
    • Stock Information
      • Stock Quote
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Financial Information
      • SEC Filings
      • Proxy Online
    • Investor Resources
      • Information Request
      • E-mail Alerts
      • IR Contact
  • News
    • Press Releases
  • Contact Us
    • Contact Us
    • Careers
  • Search

Events & Presentations

You are here:Home/Investors/ Events & Presentations

Events & Presentations

KindredBio Corporate Presentation
Download Presentation

Events and Presentations

  • Upcoming Events
  • Past Events
Upcoming Events
There are currently no events scheduled

Investor Relations

  • Investor Overview
  • Press Releases
  • Events and Presentations
  • Corporate Governance
    • Governance Documents
    • Committee Composition
  • Stock Information
    • Stock Quote
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financial Information
    • SEC Filings
    • Proxy Online
  • Investor Resources
    • Information Request
    • E-mail Alerts
    • IR Contact

INVESTOR TOOLS

  • Print Page
  • RSS Feeds
  • E-mail Alerts
  • IR Contact

News

  • Kindred Biosciences Initiates Pivotal Efficacy Study of Tirnovetmab (Interleukin-31) Monoclonal Antibody for Canine Atopic DermatitisDecember 22, 2020 8:31 AM EST
  • Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study for Anti-TNFα Antibody for Canine Inflammatory Bowel DiseaseDecember 21, 2020 8:31 AM EST
  • Kindred Biosciences Announces Agreement Granting Elanco Exclusive Global Rights for its Parvovirus Monoclonal AntibodyDecember 11, 2020 8:00 AM EST

Events

  • Kindred Biosciences Inc at the Guggenheim Animal Health Summit
    Monday, December 7, 2020 10:00 AM EST
  • Kindred Biosciences Inc at A.G.P. Virtual Healthcare Symposium
    Thursday, November 19, 2020
  • Kindred Biosciences Inc at Stifel Virtual Healthcare Conference
    Tuesday, November 17, 2020 from 2:40 PM to 3:10 PM EST
 
(Common Stock)
Previous Close Volume
Intraday High Intraday Low
52 Week High 52 Week Low
Exchange:

KindredBio proudly supports
Rabies Free Africa
Rabies free Africa

© Copyright 2012-2021 | Kindred Biosciences, Inc. | 1555 Bayshore Hwy. Suite 200 Burlingame, CA 94010 | Privacy Policy| Website Terms of Use| Forward Looking Statements
Scroll to top